Lundh's test

Lundh's test is a medical procedure used to diagnose pancreatic disease. It was developed by the Swedish surgeon Lennart Lundh in the 1960s. The test involves the administration of a hormone called secretin that stimulates the pancreas to release its digestive juices into the small intestine. The contents of the small intestine are then collected and analyzed for the presence of pancreatic enzymes.

Procedure[edit | edit source]

The Lundh's test is performed in a hospital or clinic setting. The patient is asked to fast for at least 12 hours before the test. A thin, flexible tube called an endoscope is inserted through the mouth and into the small intestine. The hormone secretin is then administered through an intravenous (IV) line. The secretin stimulates the pancreas to release its digestive juices into the small intestine. The contents of the small intestine are then collected through the endoscope and sent to a laboratory for analysis.

Interpretation of Results[edit | edit source]

The results of the Lundh's test are interpreted by a gastroenterologist. A high level of pancreatic enzymes in the small intestine indicates a healthy pancreas. A low level of pancreatic enzymes may indicate a pancreatic disease such as pancreatitis or pancreatic cancer.

Risks and Complications[edit | edit source]

As with any medical procedure, the Lundh's test carries some risks and potential complications. These may include infection, bleeding, and reaction to the secretin. Patients should discuss these risks with their doctor before undergoing the test.

See Also[edit | edit source]

Lundh's test Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.